In vivo human lower extremity saphenous vein bypass grafts manifest flow mediated vasodilation. - Wikidata - wikimedia - TriplyDB

In vivo human lower extremity saphenous vein bypass grafts manifest flow mediated vasodilation.

In vivo human lower extremity saphenous vein bypass grafts manifest flow mediated vasodilation.

http://www.wikidata.org/entity/Q41878664

about

n-3 Polyunsaturated fatty acids supplementation in peripheral artery disease: the OMEGA-PAD trial.Association between n-3 polyunsaturated fatty acid content of red blood cells and inflammatory biomarkers in patients with peripheral artery disease.Vein graft preservation solutions, patency, and outcomes after coronary artery bypass graft surgery: follow-up from the PREVENT IV randomized clinical trial.Atazanavir improves cardiometabolic measures but not vascular function in patients with long-standing type 1 diabetes mellitus Contrary effects of the receptor tyrosine kinase inhibitor vandetanib on constitutive and flow-stimulated nitric oxide elaboration in humans Measurement of brachial artery endothelial function using a standard blood pressure cuff.Vein graft adaptation and fistula maturation in the arterial environment.Small-diameter vascular tissue engineering.Vein graft failure.Vein graft failure: from pathophysiology to clinical outcomes.Conflicting effects of atazanavir therapy on atherosclerotic risk factors in stable HIV patients: A randomized trial of regimen switch to atazanavir.Ebselen does not improve oxidative stress and vascular function in patients with diabetes: a randomized, crossover trial.Inflammation in Vein Graft Disease.

P2860

Q33819705-FC8530E9-F2D2-4012-93E1-3F2EA1BAE695 Q34391653-49205234-0005-4A4E-A87E-821A778BAB02 Q35095041-CC2A04BD-FC83-43D4-BEC6-1E30216C9AA5 Q35832866-3E4F3A21-B0F6-4B63-85A7-DF220A6FE3BA Q36100725-278C021C-907D-4187-88DD-06D2FB14A818 Q37066939-AB4C8957-29D3-4C93-9406-E0F56D9540EB Q37678560-82B581FF-07A3-4083-85B4-CFDB4E6011BB Q38108204-E86C3468-CC93-4DCF-AAD5-83E76E4E7385 Q38149507-408B8168-69BD-4C3F-8BB7-9645834185A1 Q38837879-B24AD05E-DE55-4DDA-8CD7-1501D9798CD5 Q41986602-A0F19B44-C2F5-4480-AEE6-AB14560C8716 Q45343619-9E289244-0A43-4B6C-B8FF-29A44AD07634 Q50127096-E01AFF47-85A6-4E2F-B098-A2284000BC6A

P2860

In vivo human lower extremity saphenous vein bypass grafts manifest flow mediated vasodilation.

http://www.wikidata.org/entity/Q41878664

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

In vivo human lower extremity ...... st flow mediated vasodilation.

@en

type

label

In vivo human lower extremity ...... st flow mediated vasodilation.

@en

prefLabel

In vivo human lower extremity ...... st flow mediated vasodilation.

@en

P1433

Q41878664-14A28FA0-AA51-450E-AEEF-2EE17B4434AA

P1476

Q41878664-2997A8A8-29EC-47A1-990C-06C81CC77446

P2093

Q41878664-0AA04457-7549-4102-B764-5C3CCB8CFB59

Q41878664-436639D3-449D-414E-87BA-96F631BA73FB

Q41878664-6EE65FAA-2CEE-400A-8E42-CEEE337B99E7

Q41878664-6F01D819-7CF8-45E1-B6EE-49C30F5F2E6D

P2860

Q41878664-0578D9E4-8320-4540-8B3D-80A8220801E7

Q41878664-08F59EBF-2B5E-4834-A591-C882C2226A51

Q41878664-10C87D2A-72A7-49C8-B355-8F683072ACB0

Q41878664-13E1AFBB-1B18-46E1-95D7-B6C6B6A02BDD

Q41878664-29206238-CAA4-4D0B-8728-D2B2DC749AF3

Q41878664-29A94DA0-D969-41F6-85C4-3090CF6CB786

Q41878664-3161FAC4-D0AE-482F-9A6B-C3A3902BE592

Q41878664-369B77FC-6475-45A8-828D-ABBB6FD4C1D3

Q41878664-3B12E376-0040-44A5-8B0F-6A3FD238C793

Q41878664-54B9C0BB-AA55-4B07-ABCB-D7833F9DDB54

P304

Q41878664-D9DE01DF-092B-4498-BC3A-5FC68C749145

P31

Q41878664-CDBB0B99-4BC7-4C1A-B783-9B10004F56E6

P356

Q41878664-7AD9D75F-80F6-46CE-BD12-ABBFE86B541C

P433

Q41878664-BCA4B1FC-D888-4DA0-BB77-9816A9AF8DB8

P478

Q41878664-634A7853-E08E-437B-B8A4-8D6F23B4054A

P50

Q41878664-F958C812-5C2B-4A1C-88F5-4E86F1D563F3

P577

Q41878664-74006CA5-B9EB-45B5-943F-FCCF8348804B

P5875

Q41878664-94C3D91B-9F3D-4344-B5D1-1B82E57516FC

P698

Q41878664-82065131-4C42-40C1-9AE0-AD17E1175B58

P932

Q41878664-DD8034D9-01C8-4071-AB5A-D870789811CD

P356

J.JVS.2009.06.022

P1433

Journal of Vascular Surgery

P1476

In vivo human lower extremity ...... est flow mediated vasodilation

@en

P2093

Christopher D Owens

http://www.w3.org/2001/XMLSchema#string

Marie Gerhard-Herman

http://www.w3.org/2001/XMLSchema#string

Michael S Conte

http://www.w3.org/2001/XMLSchema#string

Nicole Wake

http://www.w3.org/2001/XMLSchema#string

P2860

Heterogenous nature of flow-mediated dilatation in human conduit arteries in vivo: relevance to endothelial dysfunction in hypercholesterolemia

Role of endothelial cell denudation and smooth muscle cell dedifferentiation in neointimal formation of human vein grafts after coronary artery bypass grafting: therapeutic implications.

Endothelium-dependent responses in autogenous femoral veins grafted into the arterial circulation of the dog.

Constitutive nitric oxide synthase is expressed and nitric oxide-mediated relaxation is preserved in retrieved human aortocoronary vein grafts.

Early remodeling of lower extremity vein grafts: inflammation influences biomechanical adaptation.

Heterogeneity in conduit artery function in humans: impact of arterial size.

Does arterial shear explain the magnitude of flow-mediated dilation?: a comparison between young and older humans.

Stranger in a strange land: the pathogenesis of saphenous vein graft stenosis with emphasis on structural and functional differences between veins and arteries.

Endothelial healing in vein grafts: proliferative burst unimpaired by genetic therapy of neointimal disease.

The integrity of experimental vein graft endothelium--implications on the etiology of early graft failure.

P304

1063-1070

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JVS.2009.06.022

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P50

Joshua A. Beckman

P577

2009-08-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26740725

http://www.w3.org/2001/XMLSchema#string

P698

19679424

http://www.w3.org/2001/XMLSchema#string

P932

2783575

http://www.w3.org/2001/XMLSchema#string